ãŸãã§å¡ããµãŒã¢ã³æ³šå°ïŒïŒ REJURAN ãã¥ã¢ã«ãšãã§ã¯ãã¢ã³ãã« ãµãŒã¢ã³ã®æŽ»æ§DNAããæœåºããç¬èªæå c-PDRNïŒå æ°Žåè§£DNA:ä¿æ¹¿æåïŒ& ã»ã©ããNPïŒä¿æ¹¿æåïŒé åã§èãžã®æµžéïŒè§è³ªå±€ãŸã§ïŒãé«ããæ¿å¯çŸå®¹æ¶²ã§ãðð 2023幎ãªãªãŒãã€ã³ã° ã¹ããŒãšã€ãžã³ã°ã«ããŽãªãŒãåè³ãã å®å掟ã®ãšã€ãžã³ã°ã¢ã³ãã«ãæ¯é詊ããŠã¿ãŠãâºïž
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬190äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬106äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬12äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬13äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
SK-II ãžã§ãããã£ã¯ã¹ ãªãŒã© ãšãã»ã³ã¹ | 20,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬36äœ | ã·ãäºé²ã ãã§ãªãããã€ãäžããŠãããããã¡ãæŽããŠããã广ãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬190äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬44äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬80äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬112äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
ESTEE LAUDER ã¢ããã³ã¹ ãã€ã ãªã㢠SMR ã³ã³ãã¬ãã¯ã¹ | 12,100å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬69äœ | ããªãã§ããããªã¹ã¹ã¡ã®çŸå®¹æ¶²ã§ãâš | 詳现ãèŠã | |
Anua ããŒã¯ã¹ãããã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬34äœ | ä¿æ¹¿æåããã£ã·ããšé åãããŠããŠã ããäžæ¬ã§ããèããã£ãšããšããŸãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬19äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã |
ãªãã¿ð°ãã©ããããã®äººæ°ã¯ãã³ã
éãç®ãªãã¯ã¹ã㣠å¡ãå¿å°ããªãéããã§ããåããåããããšã¹ã£ããæãããâŠã ç¬ç¹ãªçãåã ãªãã®åããªãã ãâŠãã«ãŒãã®ãããªã¬ã ããã£ã³ãã£ã®ãããªâŠ ç¹°ãåºãã«ãã æ®éã®ãªããã¯ãªãŒã ã«ã¹ã ãŒãºã«ç¹°ãåºããªã
ãã£ãšèŠã318
38
- 2024.01.14
åã®èããé²ã ããªã±ãŒããªæ§é ã®åãä¿è·ãããããçäœèŠªåæ§ã«ãã ãã£ãçŸå®¹æå*ãé åã æ¯æ¥ã€ããããªãã€ãå¿å° ãã¿ã€ãã軜ãã€ãå¿å° ãªããã¯ãªãŒã ã®ãããªæèŠã§ã€ããããŸã èµ€ã¿ãã©ãŠã³ã«ãã£ã·ãã©ã¡ æ·±ã¿ã®ãããã©ãŠã³ã«èµ€ã¿ãå ãããããããªã«ã©ãŒ å¡ã£ãŠããæãã©ã¡ã®æè§Šãããããããããã£ã·ããŽãŒã«ãã©ã¡ïŒç¬
ãã£ãšèŠã151
13
- 2024.05.06
人æ°ã®ãã«ãŒã³ã³ãããŒã«ã«ã©ãŒãã䜿ãïŒïŒããºã£ãŠãããžãã³ã·ã€ã®æ°Žè²ã®ã³ã³ãããŒã«ã«ã©ãŒæã£ãŠããã®ã§ããäžã 䜿ãããªããâŠæè¿ãã£ãšèªåãªãã«çŽåŸããäœ¿ãæ¹ãèŠã€ããŸããïŒããŸã«ãã€ãšãã ãã©ãã«ãŒäžå°äœ¿ããããªïŒãã¿ãããªçºèšãèŠãã...
ãã£ãšèŠã149
32
- 2023.11.12
äžçãã®ãã€ã©ã€ã䜿ãïŒïŒïŒïŒ SNSã§ãã¹ã£ãŠãããã¡ã ã ãã¶äœ¿ãããã ã®ã§æ¹ããŠã¬ãã¥ãŒð èŠãç®ãçŸãããã ãšã¯ã¹ãªããªã¹ã®ã¢ããŒããåæŒããããŠãŠèžè¡åããªïŒïŒïŒïŒ ãšã«ãããã¬ã€ãªãã€ã宿ã ããŒã«ãå ¥ã£ãŠããã ãã©ã€ã¶ã€ã¶ãœãïŒããŒã«ã®ç²ãç®ç«ã€ããšãªãã
ãã£ãšèŠã147
10
- 2024.11.10
ãã£ãšããããããã£ãèã«ãªãæãã¯ãããŸãã ããªã€ãããšãèããããšããªãã匷ãæåãå ¥ã£ãŠããããã§ããªããšãããâ çŸå®¹æ¶²ã¯ããšãã¿ã®ããçœæ¿ããæ¶²äœã§ãã¿ã€ããã¹ããšãªãã¿ãã£ãšãããŸã ãããã¯ãããã¯ãããæã¯ãžã§ãªãŒé¢ã»æãåãæã¯ã¬ãŒãŒé¢ãšäž¡é¢äœ¿ããã®ãâ 圢ãé·æ¹åœ¢ã§é ¬ããã£ãœãåãŸã£ãŠè¯ãã£ãã§ã
ãã£ãšèŠã143
28
- 2024.02.24
ååã®çºå£²æã¯ãšã¬ã¯ããªãã¯ãã§ãªãŒã®æ¹ãæ©ã売ãåããŸãããã 02SC ãã§ãªãŒã¹ã¢ãŒã¯ãæé«ãªãã¬ãããªã®ã§ç±ãèªãããïŒïŒïŒ ãã ãã©ãŒãã®ã¢ã€ã·ã£ããŠã£ãŠéããæã«æ¬é çºæ®ããŠããã®æ¬åœã«èšç®ããå°œãããŠããŠããã
ãã£ãšèŠã139
10
- 2024.06.02
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
- æå
- ïŒ30mlïŒ æ°ŽãPEG-6ãã°ãªã»ãªã³ãã»ã€ãšãŠã€ãã€ããŽèãšãã¹ãBGãDPGããã€ã¢ã·ã³ã¢ããã1,2-ãããµã³ãžãªãŒã«ãã¢ããšãã©æ¶²æ±ãããŠãã³ã»ã³ã«è±ãšãã¹ãã«ã³ãŸãŠæ ¹ãšãã¹ãã¯ããã°ã¯æå®ãšãã¹ãããŒããã·ã¥ãã«ãŒããªãŒæå®ãšãã¹ãã«ã«ãããŒãã¹ã¯ã¯ã©ã³ãå æ°Žåè§£DNAãããµã³ã¿ã³ã¬ã ãæ°Žæ·»ã¬ã·ãã³ãã«ããªãªã«ã°ãªã³ãŒã«ããã¢ã«ãã³é žNaããšãã«ããã·ã«ã°ãªã»ãªã³ãããã·ã¬ã³ã°ãªã³ãŒã«ãããªãœã«ããŒã20ãã»ã©ããNPãã¢ããã·ã³ããã¬ãããŒã¹ãå°¿çŽ ããã³ãã¬ã³ã°ãªã³ãŒã«ãã¢ã«ããã³ãããµãããŒã«ãé ¢é žãã³ãã§ããŒã«ãã³ã¬ã¹ãããŒã«ãã»ãªã³ããªã¬ã€ã³é žãã©ãŠãªã«ã«ã«ããã³é žã€ããªã³ãã¢ã«ã®ã³é žNaããªã³é ž2Naãããªã¢ã¯ãªã«é žã°ãªã»ãªã«ããã«ã©ã³ããªã³é žK
ãã©ããŒãããŠããã ããŸããâš ãããããé¡ãããŸãð